The Manila Times2h
ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...
PsyPost on MSN12h
Study finds microdosing LSD is not effective in reducing ADHD symptoms
A new clinical trial has found that taking low doses of LSD twice a week does not reduce symptoms of ...